Aytu Bioscience (AYTU) has recently severed an agreement with their partner Biolidics Limited for their COVID-19 Coronavirus Test Kits. The partner states that it is
Ekso Bionics (EKSO) rallied 130% today on FDA approved robotic exoskeleton. Shares of EKSO soared Thursday, after the company said it has received 501 clearance
Aytu Bioscience (AYTU) is up 5% for the week, and is a highly attractive investment. Just recently BlackRock has increased it’s holdings by 30%. This
United Allied States (UAS) is pleased to announce a new partnership with Apollo Fintech (APL). Apollo Fintech is the leading technology company developing interconnected solutions
Enphase Energy (ENPH) has declined a whopping 18% today. The reason for this is because of alleged fraud. Enphase Energy (NASDAQ:ENPH) director Benjamin John Kortlang discloses the sale
Soliton Inc, (SOLY), is a medical development company. It develops healthcare technological devices for medical and cosmetic treatments. The firm’s devices generate planar acoustic waves
A potential acquisition and merger was in the talks between AstraZeneca (AZN) and Gilead (GILD). AstraZeneca has approached rival drugmaker Gilead about a potential merger. Neither company responded
Stocks like Norwegian Cruise Line (NCLH), Royal Caribbean (RCL), Carnival (CCL) has made explosive gains in the last day. The cruising sector is getting hot
XpresSpa Group (XSPA), A cash-strapped airport spa chain snagged $5.6 million in federal coronavirus aid weeks after warning investors that its independent auditor had raised
News may have leaked the Electra Meccanica (SOLO) may begin production of their electric vehicles in an upcoming announcement scheduled for Friday. According to a
Stockpence is currently seeking to expand our team of contributors. We’re looking for financial gurus & article writers to write about trending market news and investment ideas about the stock market.
If you’re interested please contact us!
Investing involves substantial risk. Neither the authors, the publisher, nor any of their respective affiliates make any guarantee or other promise as to any results that may be obtained from the articles herein. No reader should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, on any featured company here.
Some of the companies featured here may pay a fee to an affiliate of the publication to broaden awareness of said company.
The principals of the publication may buy or sell shares of the featured companies from time-to-time.
Join our free mailing list below to receive real-time news alerts and our next featured stock!
Investing involves substantial risk. Neither the Authors, the publisher, nor any of their respective affiliates make any guarantee or other promise as to any results that may be obtained from the articles herein. No reader should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, on any featured company here.
Some of the companies featured here may pay a fee to an affiliate of the publication to broaden awareness of said company.
The principals of the publication may buy or sell shares of the featured companies from time-to-time.
Join our free mailing list below to receive real-time news alerts and our next featured stock!
